Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial

Affiliations

• ¹ Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. sbagley@pennmedicine.upenn.edu.
• ² Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. sbagley@pennmedicine.upenn.edu.
• ³ Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. sbagley@pennmedicine.upenn.edu.
• ⁴ Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁵ Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁶ Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁷ Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁸ Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁹ Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ¹⁰ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ¹¹ Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ¹² Kite, a Gilead Company, Santa Monica, CA, USA.
• ¹³ Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ¹⁴ Clinical Immunology Laboratory, Institut Curie, Paris, France.
• ¹⁵ Université Paris Cité, INSERM, PARCC, Paris, France.
• ¹⁶ Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Donald.O'Rourke@pennmedicine.upenn.edu.
• ¹⁷ Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Donald.O'Rourke@pennmedicine.upenn.edu.
• ¹⁸ Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Donald.O'Rourke@pennmedicine.upenn.edu.